Page last updated: 2024-10-27

flurbiprofen and Benign Neoplasms, Brain

flurbiprofen has been researched along with Benign Neoplasms, Brain in 1 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Research Excerpts

ExcerptRelevanceReference
" In an attempt to find an effective treatment, we examined the efficacy of the non-steroidal anti-inflammatory drug, flurbiprofen, to suppress the growth of tumor cell lines derived from medulloblastoma and glioblastoma multiforme."3.71Inhibition of human brain tumor cell growth by the anti-inflammatory drug, flurbiprofen. ( Khalili, K; King, JG, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
King, JG1
Khalili, K1

Other Studies

1 other study available for flurbiprofen and Benign Neoplasms, Brain

ArticleYear
Inhibition of human brain tumor cell growth by the anti-inflammatory drug, flurbiprofen.
    Oncogene, 2001, Oct-18, Volume: 20, Issue:47

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Brain Neoplasms; Cell Cycle; Cell Division; Cyclin B; Cyclo

2001